No Data
No Data
Needham Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $4
Analysts Offer Insights on Healthcare Companies: Biohaven Ltd. (BHVN), Arrowhead Pharmaceuticals (ARWR) and Heron Therapeutics (HRTX)
Heron Therapeutics Secures Revenue Stream With Court Ruling, Analyst Recommends Buy
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Sector Update: Health Care Stocks Steady Pre-Bell Wednesday
Traders Await Powell Comments as US Equity Futures Post Premarket Gains